Search results for "Research"
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, I.M. Matters Weekly from ACP.
https://immattersacp.org/archives/2024/05/latest-updates-on-acps-priorities-initiatives.htm
1 May 2024
Remove stigma from licensure, credentialing applications
Applications often include vague questions about applicants' mental health diagnoses and treatment history, such as whether an applicant has ever received treatment for a mental health condition that could impair their ability to practice medicine.
https://immattersacp.org/archives/2024/05/remove-stigma-from-licensure-credentialing-applications.htm
1 May 2024
CDC and FDA weigh in on safety of bivalent vaccine; research examines COVID-19 sequelae, omicron variants
The CDC and FDA said an observed association of ischemic stroke with the Pfizer-BioNTech bivalent booster is very unlikely to represent a true clinical risk. New studies reported on symptoms a year after mild COVID-19 and estimated protection against the omicron variants.
https://immattersacp.org/weekly/archives/2023/01/24/2.htm
24 Jan 2023
Women's health rights drive expansion of ACP policy
ACP's positions on women's health policy have grown from a few paragraphs into position papers, policies, and most importantly, progress.
https://immattersacp.org/archives/2024/05/womens-health-rights-drive-expansion-of-acp-policy.htm
1 May 2024
Frequency of COVID-19 rebound debated in research, ACP/Annals forum
Two letters reported on SARS-CoV-2 viral rebound among patients taking nirmatrelvir-ritonavir. The latest ACP and Annals of Internal Medicine forum brought experts together to discuss this and other clinical challenges in COVID-19 prevention and management on Wednesday, Sept. 7.
https://immattersacp.org/weekly/archives/2022/09/13/2.htm
13 Sep 2022
Latest COVID-19 research on VTE risk, treatment with metformin, ivermectin, fluvoxamine
Unvaccinated patients may have higher risk of venous thromboembolism (VTE) when mildly ill, one study found, while another showed no effect from metformin, ivermectin, or fluvoxamine. Research supported the safety of the mRNA vaccines, and the NIH updated its treatment guidelines.
https://immattersacp.org/weekly/archives/2022/08/23/4.htm
23 Aug 2022
Controlling hypertension, curing HCV, and more stories
Helping a patient get their hypertension under control is one thing, but helping them keep it there is quite another.
https://immattersacp.org/archives/2024/05/controlling-hypertension-curing-hcv-and-more-stories.htm
1 May 2024
Latest pandemic research looks at persistent symptoms of COVID-19, rise in alcohol deaths
More than half of patients with mild COVID-19 reported symptoms months later in one study, while another found psychiatric and neurologic consequences were similar in ICU survivors with and without COVID-19. Other research looked at the rise in alcohol-related deaths and the safety of vaccination during pregnancy.
https://immattersacp.org/weekly/archives/2022/03/29/4.htm
29 Mar 2022
Is AI OK for IM?
While generative artificial intelligence systems such as ChatGPT could potentially revolutionize the practice of medicine, their role must be carefully assessed, with humans, especially physicians, in firm control of interpreting output.
https://immattersacp.org/archives/2024/03/is-ai-ok-for-im.htm
1 Mar 2024
Research looks at out-of-pocket prescription costs
One study evaluated the effect of real-time pop-up recommendations for lower-priced prescription alternatives, while a second study modeled capping monthly expenses and shifting the patients' savings back to the insurance plan.
https://immattersacp.org/weekly/archives/2022/09/20/2.htm
20 Sep 2022